Strategic Reshuffling in Hong Kong's Healthcare Cluster Amid Global Supply Chain ShiftsGlobal Report·20 hours ago03320-0.21%01833+0.90%
Winners and Sleepwalkers in a Bizarre HK Sector Mashup: Here Is Why It MattersGlobal Report·1 day ago, 04:17 AM03320-0.21%02865-0.85%
China Resources Pharmaceutical Moves to Become Largest Shareholder in Lier ChemicalTip Ranks·2 days ago, 05:37 PM002258-1.73%03320-0.21%
China Resources Pharma unit CR Pharmaceutical Holdings issues RMB 1 billion 3-year notes at 1.52% couponPUBT·2 days ago, 05:39 AM03320-0.21%
Liquidity spillovers trigger a structural repricing in Hong Kong's unclassified cornersGlobal Report·Jul 25 at 04:14 AM09600-8.23%013410.00%
China Resources Pharma unit tops bid to buy 23.5% stake in Lier ChemicalPUBT·Jul 15 at 09:12 AM002258-1.73%600062+0.25%
Tasly Delivers Profit Growth on Flat Revenue, Bolstering China Resources PharmaceuticalTip Ranks·Jul 14 at 07:08 AM03320-0.21%600535+1.51%
China Resources Pharmaceutical files board, committee and disclosure-responsible management listPUBT·Jul 13 at 03:34 AM03320-0.21%
China Resources Pharmaceutical appoints Zhang Jing as non-executive directorPUBT·Jul 13 at 03:34 AM03320-0.21%
China Resources Pharmaceutical declares 2025 final dividend of RMB 0.122 a sharePUBT·Jun 29 at 05:09 PM03320-0.21%
China Resources Pharmaceutical Raises RMB2 Billion in Third Tranche of 2026 PRC BondsTip Ranks·Jun 26 at 07:18 AM03320-0.21%
23:56 ETChina Resources Group Participates in the 4th CISCE, Unveils "China Resources Low-Carbon Eco-Community"prnewswire·Jun 22 at 10:57 PM03320-0.21%00836-0.41%
CHINARES PHARMAs Innovative Drug BGM0504 for Weight Loss Has NDA AcceptedAASTOCKS News·Jun 15 at 04:40 AM03320-0.21%
